Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: "Yes, the licensing can continue."GKrichard
5
Aug 18, 2010 09:45AM

So you think that TPL will holdoff collecting MMP licenses.... something that generated over $150 million for TPL in the past few years?? because of a 1 million claim...

Share
New Message
Please login to post a reply